| Biotechnology Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 96 Employees | - Last Dividend | - Last Split | - IPO Date |
NIBEC Co., Ltd., founded in 2004 and based in Jincheon-eup, South Korea, is at the forefront of developing innovative solutions for tissue regeneration. The company is dedicated to the research and development, manufacture, and sale of cutting-edge tissue regeneration devices. Leveraging advanced technologies, NIBEC focuses on the creation of peptide-based fusion products, regenerative biomaterials, cosmetics, and oral care products. Its commitment to improving health and wellbeing is underscored by its extensive product portfolio, which is designed to meet the needs of patients and consumers in South Korea and beyond. The company's relentless pursuit of innovation and excellence in the field of biotechnology has positioned it as a leader in regenerative medicine, offering solutions that enhance the body's natural healing process.